How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,595 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion

Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 36, Issue 3, Pages 266–274 Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion PRINCIPAL AUTHORS, x Sheila Caddy , MD Edmonton AB x Mark H. Yudin , MD Toronto ON x Julie Hakim , MD (...) SPECIAL CONTRIBUTOR x Wendy V. Norman , MD x Wendy V. Norman DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Abstract Background Intrauterine devices provide an extremely effective, long-term form of contraception that has the benefit of being reversible. Historically, the use of certain intrauterine devices was associated with increased risk of pelvic inflammatory disease. More recent evidence suggests that newer devices do not carry

2014 Society of Obstetricians and Gynaecologists of Canada

22. Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity

Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity Prescrire IN ENGLISH - Spotlight ''Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity'', 1 December 2014 {1} {1} {1} | | > > > Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |  (...)  |   |   |   |   |  Spotlight Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity For overweight or obese women requiring emergency contraception, the fitting of an intrauterine device (IUD) is the first choice. Fitting a copper IUD within 5 days of unprotected sexual intercourse is a very effective means of postcoital or emergency contraception. A single dose of the progestin contraceptive levonorgestrel

2014 Prescrire

23. Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion

Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion 404 Toggle navigation Toggle search Keyword search language Keyword search 404 Error Page/Asset Not Found The Society of Obstetricians and Gynaecologists of Canada (SOGC) {1} {1} {1}

2014 Society of Obstetricians and Gynaecologists of Canada

24. [Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion]. (PubMed)

[Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion]. To compare the effectiveness of medicated γ intrauterine device (IUD) and medicated genefix IUD inserted immediately after abortion.A multicenter clinical trail was performed for the study from Mar. 2012 to Jan. 2013. Totally 840 women who volunteered to participate were randomly allocated to γ-group (medicated γ IUD) or genefix-group (medicated genefix IUD

2016 Zhonghua fu chan ke za zhi

25. Chronic nodules of sigmoid perforation caused by incarcerated intrauterine contraception device. (PubMed)

Chronic nodules of sigmoid perforation caused by incarcerated intrauterine contraception device. It is extremely rare for an intrauterine contraception device (IUD) to cause uterine perforation and Sigmoid perforation for a long time without being detected.We present a case of a patient who has suffered from abdominal pain after 4 years of placement of an IUD, and found that the IUD was incarcerated by ultrasound.Laparoscopic and hysteroscopic examination revealed that the incarcerated IUD (...) caused uterine perforation and sigmoid perforation for a long time. One end of the intrauterine device completely penetrated the anterior wall muscle layer of the uterus and the full layer of the sigmoid colon, located in the intestinal lumen, and the perforated portion of the sigmoid colon formed a chronic nodule.We extended the sigmoid colon perforation and uterine perforation by laparoscopy, removed the incarcerated IUD from the uterus through the vagina, trimmed the chronic nodules of the sigmoid

2019 Medicine

26. Evaluating different pain lowering medications during intrauterine device insertion: a systematic review and network meta-analysis. (PubMed)

Evaluating different pain lowering medications during intrauterine device insertion: a systematic review and network meta-analysis. To synthesize the evidence on the most effective medications for the relief of intrauterine device (IUD) insertion-related pain.Systematic review and network meta-analysis of randomized controlled trials (RCTs).Not applicable.Patients undergoing IUD insertion who received different medications for pain relief versus those who received placebo.Electronic search

2019 Fertility and Sterility

27. Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women

Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women To estimate the effect of a 1% lidocaine paracervical nerve block on pain during intrauterine device (IUD) insertion compared with a sham block in adolescents and young women.We conducted a multisite, single-blind, sham-controlled randomized trial in adolescents and young women having a 13.5-mg levonorgestrel IUD inserted. Enrollment occurred at three family planning clinics

2017 EvidenceUpdates

28. Intrauterine Device Insertion Procedure Duration in Adolescent and Young Adult Women. (PubMed)

Intrauterine Device Insertion Procedure Duration in Adolescent and Young Adult Women. Intrauterine device (IUD) utilization in the United States is low among adolescent and young adult women. Longer procedure duration has been proposed as one potential barrier to IUD insertion in this population. We hypothesized that procedure duration would be longer in adolescents compared to young adult women.This study was a secondary analysis of a randomized clinical trial comparing the effectiveness

2019 Journal of pediatric and adolescent gynecology

29. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. (PubMed)

Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. 30575660 2018 12 21 1873-233X 133 1 2019 Jan Obstetrics and gynecology Obstet Gynecol Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. 189 10.1097/AOG.0000000000003043 Levine Elliot M EM Department of Obstetrics and Gynecology, Advocate Aurora Health Illinois Masonic Medical Center, Chicago, Illinois. Fernandez Carlos M CM eng

2019 Obstetrics and Gynecology

30. Migration of an intrauterine device causing severe hydronephrosis progressing to renal failure: A case report. (PubMed)

Migration of an intrauterine device causing severe hydronephrosis progressing to renal failure: A case report. Intrauterine device (IUD) is commonly used in China. Its complications include uterine perforation, IUD ectopic migration, etc. However, a migrated IUD rarely leads to renal failure.IUD insertion in the patient was followed by unexplained pain in the left renal area, without bladder irritation or dysuresia.Hydronephrosis, renal failure, migrated IUD.The patient underwent laparoscopic

2019 Medicine

31. Factors affecting the behavior outcomes on post-partum intrauterine contraceptive device uptake and continuation in Nepal: a qualitative study. (PubMed)

Factors affecting the behavior outcomes on post-partum intrauterine contraceptive device uptake and continuation in Nepal: a qualitative study. The use of post-partum family planning (PPFP) methods such as post-partum intrauterine device (PPIUD) in general remains low despite its benefits for the women. The reasons or factors affecting the uptake and continuation of such PPFP methods in developing countries such as Nepal remains unclear. This qualitative research aims to explore the factors

Full Text available with Trip Pro

2019 BMC Pregnancy and Childbirth

32. Extensive intravesical benign hyperplasia induced by an extravesical migrated intrauterine device: A case report. (PubMed)

Extensive intravesical benign hyperplasia induced by an extravesical migrated intrauterine device: A case report. Intravesical migrated intrauterine devices (IUDs) have been reported to cause bladder perforation, stone formation, or malignant transition. However, such extensive intravesical benign hyperplasia caused by an extravesical migrated IUD is firstly reported.A 38-year-old woman suffered from recurrent urinary urgency and dysuria and without macroscopic hematuria for about 1

Full Text available with Trip Pro

2019 Medicine

33. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. (PubMed)

A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. To compare the expulsion rate at 6 months after postplacental insertion by intrauterine device (IUD) type.This prospective cohort included participants with a postplacental IUD inserted after vaginal or cesarean delivery, aged 18-45 and ≥24 weeks' gestation. Study enrollment took place after IUD selection and insertion. Participants returned for a postpartum (...) , 95% confidence interval 0.22-4.48).The expulsion rate at 6 months after postplacental insertion did not differ between the levonorgestrel and copper IUD type.Prior studies demonstrate a wide range of expulsion after postplacental insertion, and recent data suggest a higher expulsion rate for the levonorgestrel compared to the copper intrauterine device. However, many studies did not control for patient-level factors or delivery route. We found that when controlling for these confounding variables

2019 Contraception

34. New developments in intrauterine device use: focus on the US (PubMed)

New developments in intrauterine device use: focus on the US Many more women in the US today rely upon intrauterine devices (IUDs) than in the past. This increased utilization may have substantially contributed to the decline in the percentage of unintended pregnancies in the US. Evidence-based practices have increased the number of women who are medically eligible for IUDs and have enabled more rapid access to the methods. Many women enjoy freedom to use IUDs without cost, but for many

Full Text available with Trip Pro

2016 Open access journal of contraception

35. Intrauterine devices and risk of uterine perforation: current perspectives (PubMed)

Intrauterine devices and risk of uterine perforation: current perspectives Uterine perforation is an uncommon complication of intrauterine device insertion, with an incidence of one in 1,000 insertions. Perforation may be complete, with the device totally in the abdominal cavity, or partial, with the device to varying degrees within the uterine wall. Some studies show a positive association between lactation and perforation, but a causal relationship has not been established. Very rarely (...) , a device may perforate into bowel or the urinary tract. Perforated intrauterine devices can generally be removed successfully at laparoscopy.

Full Text available with Trip Pro

2016 Open access journal of contraception

36. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy

Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy - ACOG Menu ▼ Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Page Navigation ▼ Number 642, October 2015 (Replaces Committee Opinion Number 450, December 2009) (Reaffirmed 2018) Committee on Gynecologic Practice Long-Acting Reversible (...) Contraception Working Group This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy ABSTRACT: Unintended pregnancy persists as a major public health problem in the United States. Although lowering unintended pregnancy rates requires

2015 American College of Obstetricians and Gynecologists

37. Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion. (PubMed)

Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion. The most effective and safe contraceptive method, intrauterine devices (IUDs), is still underutilized due to the pain barrier during IUD insertion. Lidocaine, a well-known local anesthetic, can be used to relieve IUD insertion pain. This study aimed at formulation, in vitro, in vivo and clinical evaluation of a novel lidocaine dual-responsive in situ gel. Pluronic and Gelrite® were used as thermosenstive

2018 International journal of pharmaceutics

38. Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomised control trial. (PubMed)

Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomised control trial. 29260589 2018 04 27 2018 12 02 1473-0782 23 2 2018 04 The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception Eur J Contracept Reprod Health Care Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomised control trial. 165 10.1080/13625187.2017.1413180 Abbas Ahmed M AM (...) a Department of Obstetrics and Gynecology, Faculty of Medicine , Assiut University , Assiut , Egypt. eng Letter Comment 2017 12 20 England Eur J Contracept Reprod Health Care 9712127 1362-5187 IM Eur J Contracept Reprod Health Care. 2017 Oct;22(5):349-353 28978240 Humans Intrauterine Device Expulsion Intrauterine Devices Intrauterine Devices, Medicated 2017 12 21 6 0 2018 4 28 6 0 2017 12 21 6 0 ppublish 29260589 10.1080/13625187.2017.1413180

2018 The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

39. Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial. (PubMed)

Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial. To reduce the pain and duration of the intrauterine device (IUD) insertion procedure through minimizing instrumentation and using trans-abdominal sonography (TAS).This randomized control trial was conducted in a university hospital and included 102 eligible females, fulfilling the inclusion criteria. They were randomly assigned into two groups via 1:1 computer-based randomization

2018 The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

40. Oral Ketorolac for Pain Relief During Intrauterine Device Insertion: A Double-Blinded Randomized Controlled Trial. (PubMed)

Oral Ketorolac for Pain Relief During Intrauterine Device Insertion: A Double-Blinded Randomized Controlled Trial. To evaluate if oral ketorolac provides effective pain relief during placement of an IUD for contraception.We conducted a double-blinded randomized controlled trial in a community hospital in Columbus, Ohio. Participants that met eligibility criteria were consented and randomized to receive either oral ketorolac 20 mg or placebo 40 to 60 minutes before IUD placement. Both

2018 Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>